Polysaccharide Biomaterials in Cancer Research and Therapy: From Lab to Life

Revolutionize your approach to oncology with this guide to mastering the interdisciplinary intersection of green chemistry and clinical research, where polysaccharide-based innovations provide a safer, biocompatible, and sustainable frontier for cancer treatment.

Cancer continues to be a major global health issue, impacting millions of individuals annually. Although traditional cancer treatments have improved, there is a rising demand for alternative and complementary medicines that may provide advantages with fewer side effects. Polysaccharides, which are complex sugars found in plants, fungi, and microbes, are considered for cancer research and treatment because of their many biological effects, compatibility with living organisms, and low toxicity. In recent years, the area of polysaccharide-based cancer treatment has seen substantial expansion. This book provides a thorough summary of the present status of research and advancements in polysaccharide-based cancer treatment. It delves into the interdisciplinary and rapidly evolving field of biomedical research that intersects with pharmaceutics, oncology, and materials science. There is a growing focus on treatment methods that are both more sustainable and safer, in line with the ideas of green chemistry and personalized medicine. This book documents a crucial stage in the advancement of various fields, including materials science, biotechnology, and clinical oncology, offering new therapies that are better aligned with the human body and the environment.

Readers will find the volume:

• Introduces the structural features, properties, and biological effects of polysaccharides that are pertinent to cancer research and treatment;
• Examines recent progress in polysaccharide-based drug delivery technologies, immunomodulatory effects, and targeted therapeutic strategies;
• Showcases case studies, clinical trials, and translational research that illustrate the efficacy of polysaccharides in enhancing treatment results and patient well-being;
• Discusses obstacles, possibilities, and future directions for advancing research using polysaccharide-based cancer treatments;
• Acts as a resource for anyone interested in the function of polysaccharides in cancer research and therapy, promoting multidisciplinary cooperation.

Audience

Academics, researchers, and professionals in oncology, biomedical engineering, nanotechnology, and drug delivery systems, specifically cancer researchers, biotechnologists, pharmaceutical scientists, and clinicians interested in biomaterials and advanced therapeutic strategies.

Luqman Jameel Rather, PhD is a postdoctoral researcher at the College of Sericulture, Textile and Biomass Science, Southwest University, Chongqing, P.R. China. He has authored more than 80 research publications and edited two books. His expertise spans nanomaterial-based textiles, antimicrobial and UV-protective coatings, eco-friendly dyeing techniques, and biomedical applications of biopolymers.

Showkat Ali Ganie, PhD is a postdoctoral fellow in the College of Sericulture, Textile and Biomass Science, Southwest University, Chongqing, P.R. China. He has published numerous research articles in various reputed peer-reviewed journals and several book chapters. His areas of research include the chemical functionalization of biopolymers and polymers through organic reactions for various applications like drug delivery, biomaterials, biomedical applications, and hydrogels.

Mohammed A. Assiri, PhD is an Associate Professor in the Department of Chemistry, Faculty of Science, King Khalid University, Abha, Saudi Arabia. His research focuses on the design, synthesis, and chemical reactivity of chromone and 1,2,4-triazine compounds containing sulfur and phosphorus heterocycles and the design, synthesis, and characterization of novel classes of α-amino-phosphonate and α-hydrazinophosphonate bearing different heterocyclic systems with new biological properties.